Farallon Capital Management’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-496,890
| Closed | -$7.75M | – | 330 |
|
|
2022
Q1 | $7.75M | Sell |
496,890
-13,110
| -3% | -$204K | 0.04% | 154 |
|
|
2021
Q4 | $10.9M | Hold |
510,000
| – | – | 0.05% | 125 |
|
|
2021
Q3 | $14.3M | Hold |
510,000
| – | – | 0.07% | 118 |
|
|
2021
Q2 | $15.1M | Hold |
510,000
| – | – | 0.06% | 110 |
|
|
2021
Q1 | $16.3M | Hold |
510,000
| – | – | 0.08% | 110 |
|
|
2020
Q4 | $18.3M | Buy |
510,000
+5,000
| +1% | +$180K | 0.11% | 89 |
|
|
2020
Q3 | $19.2M | Buy |
505,000
+5,000
| +1% | +$190K | 0.13% | 84 |
|
|
2020
Q2 | $17.5M | Sell |
500,000
-250,000
| -33% | -$8.75M | 0.14% | 91 |
|
|
2020
Q1 | $25.9M | Sell |
750,000
-259,800
| -26% | -$8.96M | 0.22% | 60 |
|
|
2019
Q4 | $33.5M | Sell |
1,009,800
-200
| -0% | -$6.64K | 0.23% | 65 |
|
|
2019
Q3 | $25.6M | Buy |
1,010,000
+10,000
| +1% | +$254K | 0.19% | 60 |
|
|
2019
Q2 | $21.6M | Buy |
1,000,000
+51,300
| +5% | +$1.11M | 0.14% | 74 |
|
|
2019
Q1 | $16.1M | Buy |
948,700
+48,700
| +5% | +$829K | 0.12% | 75 |
|
|
2018
Q4 | $10.4M | Hold |
900,000
| – | – | 0.08% | 78 |
|
|
2018
Q3 | $14.9M | Hold |
900,000
| – | – | 0.09% | 75 |
|
|
2018
Q2 | $11.4M | Buy |
900,000
+35,000
| +4% | +$444K | 0.07% | 74 |
|
|
2018
Q1 | $13M | Buy |
865,000
+215,000
| +33% | +$3.23M | 0.09% | 67 |
|
|
2017
Q4 | $8.84M | Hold |
650,000
| – | – | 0.07% | 67 |
|
|
2017
Q3 | $12.5M | Buy |
+650,000
| New | +$12.5M | 0.11% | 65 |
|